+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Digiceuticals Market Report and Forecast 2024-2032

  • PDF Icon


  • 140 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895131
The global digiceuticals market size was valued at USD 6.1 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 32.5% during the forecast period of 2024-2032 to achieve a value of USD 76.7 billion by 2032.

Digiceuticals: Introduction

Digiceuticals, short for digital therapeutics, refers to software-based interventions designed to treat medical conditions. These digital health solutions often leverage technology, such as mobile apps or software programs, to deliver evidence-based therapeutic interventions. Digiceuticals can target various health issues, including mental health disorders, chronic diseases, and lifestyle-related conditions, offering a novel approach to complement traditional medical treatments and enhance patient outcomes through personalized, technology-driven interventions.

Key Trends in the Global Digiceuticals Market

In recent years, the global digiceuticals market has undergone transformative trends, reflecting a paradigm shift in healthcare towards digital therapeutics. Witnessing increased acceptance, these software-based interventions address diverse health concerns.

Notably, there's a surge in digiceuticals focusing on mental health, offering solutions for anxiety and depression exacerbated by the COVID-19 pandemic. Chronic disease management sees a significant boost, leveraging remote monitoring and personalized interventions.

The synergy between digiceuticals and wearables intensifies, enhancing real-time health monitoring. Artificial intelligence and machine learning algorithms play a pivotal role in tailoring interventions, predicting health outcomes, and adapting therapeutic approaches based on patient data.

Integral to telehealth services, digiceuticals contribute to a comprehensive remote healthcare experience. The collaboration between pharmaceutical entities and digital health firms is expanding, integrating digiceuticals into treatment plans.

Beyond medical conditions, digiceuticals extend into behavioural health interventions, lifestyle management, and preventive care. Patient engagement platforms are developed to improve user experience and long-term adherence to digital therapeutic programs. With a focus on remote patient monitoring, digiceuticals mark a transformative era in healthcare, embracing technology-driven, personalized interventions for improved patient outcomes.

Global Digiceuticals Market Segmentation

Market Breakup by Type

  • Software
  • Devices

Market Breakup by Application

  • Mental Health
  • Chronic Disease Management
  • Medication Adherence
  • Others

Market Breakup by End User

  • Hospital
  • Specialty Clinics

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Digiceuticals Market Overview

Digiceuticals are gaining traction globally, with variations in adoption and implementation across different continents. Factors such as technological infrastructure, regulatory frameworks, and healthcare needs contribute to the evolving landscape of the digiceuticals market in various regions.

North America, particularly the United States, has been at the forefront of adopting digital therapeutics. Factors such as advanced healthcare infrastructure, technological innovation, and supportive regulatory environments contribute to the prominence of digiceuticals in the region. There's an increased focus on mental health applications and chronic disease management.

European countries have been embracing digital health solutions, including digiceuticals, with a growing emphasis on integrating these technologies into existing healthcare systems. Regulatory frameworks are adapting to accommodate digital therapeutics, contributing to their incorporation into clinical practice.

The Asia Pacific region is witnessing an expanding interest in digital therapeutics, aligning with the region's technological advancements and rising healthcare awareness. The potential for digiceuticals is significant, especially in populous countries with increasing healthcare needs.

Global Digiceuticals Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

  • Pear Therapeutics
  • Akili Interactive Labs
  • Click Therapeutics
  • Omada Health
  • Happtique
  • WellDoc
  • Propeller Health (a subsidiary of ResMed)
  • Canary Health, Inc.
  • Glooko, Inc.
  • 2Morrow
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Digiceuticals Market Overview
3.1 Global Digiceuticals Market Historical Value (2017-2023)
3.2 Global Digiceuticals Market Forecast Value (2024-2032)
4 Global Digiceuticals Market Landscape
4.1 Global Digiceuticals: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Digiceuticals: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Digiceuticals Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Digiceuticals Market Segmentation
6.1 Global Digiceuticals Market by Type
6.1.1 Market Overview
6.1.2 Software
6.1.3 Devices
6.2 Global Digiceuticals Market by Application
6.2.1 Market Overview
6.2.2 Mental Health
6.2.3 Chronic Disease Management
6.2.4 Medication Adherence
6.2.5 Others
6.3 Global Digiceuticals Market by End User
6.3.1 Market Overview
6.3.2 Hospital
6.3.3 Specialty Clinics
6.4 Global Digiceuticals Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Digiceuticals Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Digiceuticals Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Digiceuticals Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Digiceuticals Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Digiceuticals Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Pear Therapeutics
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Akili Interactive Labs
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Click Therapeutics
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Omada Health
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Happtique
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 WellDoc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Propeller Health (a subsidiary of ResMed)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Canary Health, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Glooko, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 2Morrow
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • Pear Therapeutics
  • Akili Interactive Labs
  • Click Therapeutics
  • Omada Health
  • Happtique
  • WellDoc
  • Propeller Health (a subsidiary of ResMed)
  • Canary Health Inc.
  • Glooko Inc.
  • 2Morrow